Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase III trial of Aliminase in ulcerative colitis initiated

April 9, 1999

VRT-21493: a representative new HCV NS3 protease inhibitor designed by Vertex

April 8, 1999

Available for licensing from NIH: cloned genomes of infectious HCV and uses thereof

April 8, 1999

Nabi receives FDA approval, launches anti-hepatitis B product

April 5, 1999

SciClone receives another approval for Zadaxin

April 1, 1999

S-0509 exhibits potent gastric acid antisecretory effects in animal models

March 31, 1999

Enrollment completed for trial of InKine purgative tablets

March 29, 1999

Lilly and Ribozyme to collaborate on new HCV treatment

March 26, 1999

Hokuriku Seiyaku discusses new agents for constipation at Japanese meeting

March 25, 1999

CCK-A antagonist from Zeria shows promising activity in pancreatitis models

March 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...